Vaccine against autoimmune disease: Can helminths or their products provide a therapy?

Current Opinion in Immunology

Volumn 25, Issue 3, 2013, Pages 418-423

  Zaccone, Paola ^a   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ES 62; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENTERITIS; FASCIOLA HEPATICA; GRAVES DISEASE; HELIGMOSOMOIDES POLYGYRUS; HELMINTHIASIS; INCIDENCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LITOMOSOIDES SIGMODONTIS; MULTIPLE SCLEROSIS; NECATOR AMERICANUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMA MANSONI; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; TH2 CELL; TRICHINELLA SPIRALIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HELMINTHS; HUMANS; INFLAMMATION; VACCINES;

EID: 84879234701     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.02.006     Document Type: Review

References (56)

1. Patterson C.C., Dahlquist G.G., Gyurus E., Green A., Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373:2027-2033.
2. Greenwood B.M. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968, 2:380-382.
3. Greenwood B.M., Herrick E.M., Voller A. Suppression of autoimmune disease in NZB and (NZB×NZW) F1 hybrid mice by infection with malaria. Nature 1970, 226:266-267.
4. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
5. Sotgiu S., Angius A., Embry A., Rosati G., Musumeci S. Hygiene hypothesis: innate immunity, malaria and multiple sclerosis. Med Hypotheses 2008, 70:819-825.
6. Smith K.G., Clatworthy M.R. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010, 10:328-343.
7. Sotgiu S., Sannella A.R., Conti B., Arru G., Fois M.L., Sanna A., Severini C., Morale M.C., Marchetti B., Rosati G., et al. Multiple sclerosis and anti-Plasmodium falciparum innate immune response. J Neuroimmunol 2007, 185:201-207.
8. Correale J., Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007, 61:97-108.
9. Cooke A., Tonks P., Jones F.M., O'Shea H., Hutchings P., Fulford A.J., Dunne D.W. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999, 21:169-176.
10. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980, 29:1-13.
11. La Flamme A.C., Ruddenklau K., Backstrom B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003, 71:4996-5004.
12. Nagayama Y., Watanabe K., Niwa M., McLachlan S.M., Rapoport B. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 2004, 173:2167-2173.
13. Osada Y., Shimizu S., Kumagai T., Yamada S., Kanazawa T. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 2009, 39:457-464.
14. Hubner M.P., Stocker J.T., Mitre E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 2009, 127:512-522.
15. Saunders K.A., Raine T., Cooke A., Lawrence C.E. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 2007, 75:397-407.
16. Elliott D.E., Setiawan T., Metwali A., Blum A., Urban J.F., Weinstock J.V. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004, 34:2690-2698.
17. Walsh K.P., Brady M.T., Finlay C.M., Boon L., Mills K.H. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 2009, 183:1577-1586.
18. van Die I., Cummings R.D. Glycan gimmickry by parasitic helminths: a strategy for modulating the host immune response?. Glycobiology 2010, 20:2-12.
19. MacDonald A.S., Straw A.D., Dalton N.M., Pearce E.J. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol 2002, 168:537-540.
20. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., Cooke A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003, 33:1439-1449.
21. Spits H., Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012, 30:647-675.
22. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 2009, 27:551-589.
23. Taylor M.D., van der Werf N., Maizels R.M. T cells in helminth infection: the regulators and the regulated. Trends Immunol 2012, 33:181-189.
24. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
25. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
26. Hubner M.P., Shi Y., Torrero M.N., Mueller E., Larson D., Soloviova K., Gondorf F., Hoerauf A., Killoran K.E., Stocker J.T., et al. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J Immunol 2012, 188:559-568.
27. Zaccone P., Burton O., Miller N., Jones F.M., Dunne D.W., Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 2009, 39:1098-1107.
28. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
29. Summers R.W., Elliott D.E., Qadir K., Urban J.F., Thompson R., Weinstock J.V. Trichurus suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003, 98:2034-2041.
30. Benzel F., Erdur H., Kohler S., Frentsch M., Thiel A., Harms L., Wandinger K.P., Rosche B. Immune monitoring of Trichurus suis egg therapy in multiple sclerosis patients. J Helminthol 2011, 86:339-347.
31. Fleming J.O., Isaak A., Lee J.E., Luzzio C.C., Carrithers M.D., Cook T.D., Field A.S., Boland J., Fabry Z. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 2011, 17:743-754.
32. Correale J., Farez M.F. The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 2011, 233:6-11.
33. Daveson A.J., Jones D.M., Gaze S., McSorley H., Clouston A., Pascoe A., Cooke S., Speare R., Macdonald G.A., Anderson R., et al. Effect of hookworm infection on wheat challenge in celiac disease-a randomised double-blinded placebo controlled trial. PLoS ONE 2011, 6:e17366.
34. Feary J.R., Venn A.J., Mortimer K., Brown A.P., Hooi D., Falcone F.H., Pritchard D.I., Britton J.R. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 2009, 40:299-306.
35. McSorley H.J., Gaze S., Daveson J., Jones D., Anderson R.P., Clouston A., Ruyssers N.E., Speare R., McCarthy J.S., Engwerda C.R., et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS ONE 2011, 6:e24092.
36. Gaze S., McSorley H.J., Daveson J., Jones D., Bethony J.M., Oliveira L.M., Speare R., McCarthy J.S., Engwerda C.R., Croese J., et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog 2012, 8:e1002520.
37. Tilp C., Kapur V., Loging W., Erb K.J. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. Int J Parasitol 2013.
38. Rzepecka J., Siebeke I., Coltherd J.C., Kean D.E., Steiger C.N., Al-Riyami L., McSharry C., Harnett M.M., Harnett W. The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype. Int J Parasitol 2013, 43:211-223.
39. Elliott D.E., Li J., Blum A., Metwali A., Qadir K., Urban J.F., Weinstock J.V. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003, 284:G385-G391.
40. Sewell D., Qing Z., Reinke E., Elliot D., Weinstock J., Sandor M., Fabry Z. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003, 15:59-69.
41. Burton O.T., Gibbs S., Miller N., Jones F.M., Wen L., Dunne D.W., Cooke A., Zaccone P. Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur J Immunol 2010, 40:2221-2229.
42. Zaccone P., Burton O.T., Gibbs S., Miller N., Jones F.M., Dunne D.W., Cooke A. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010, 2010:795210.
43. Atochina O., Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 2006, 15:461-468.
44. Harn D.A., McDonald J., Atochina O., Da'dara A.A. Modulation of host immune responses by helminth glycans. Immunol Rev 2009, 230:247-257.
45. Harnett M.M., Kean D.E., Boitelle A., McGuiness S., Thalhamer T., Steiger C.N., Egan C., Al-Riyami L., Alcocer M.J., Houston K.M., et al. The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis 2008, 67:518-523.
46. Imai S., Tezuka H., Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 2001, 286:1051-1058.
47. Schramm G., Mohrs K., Wodrich M., Doenhoff M.J., Pearce E.J., Haas H., Mohrs M. Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo. J Immunol 2007, 178:6023-6027.
48. Everts B., Hussaarts L., Driessen N.N., Meevissen M.H., Schramm G., van der Ham A.J., van der Hoeven B., Scholzen T., Burgdorf S., Mohrs M., et al. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med 2012, 209:1753-1767.
49. Everts B., Perona-Wright G., Smits H.H., Hokke C.H., van der Ham A.J., Fitzsimmons C.M., Doenhoff M.J., van der Bosch J., Mohrs K., Haas H., et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med 2009, 206:1673-1680.
50. Steinfelder S., Andersen J.F., Cannons J.L., Feng C.G., Joshi M., Dwyer D., Caspar P., Schwartzberg P.L., Sher A., Jankovic D. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med 2009, 206:1681-1690.
51. Zaccone P., Burton O.T., Gibbs S.E., Miller N., Jones F.M., Schramm G., Haas H., Doenhoff M.J., Dunne D.W., Cooke A. The S. mansoni glycoprotein omega-1 induces Foxp3 expression in NOD mouse CD4(+) T cells. Eur J Immunol 2011, 41:2709-2718.
52. Du L., Tang H., Ma Z., Xu J., Gao W., Chen J., Gan W., Zhang Z., Yu X., Zhou X., et al. The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice. Dig Dis Sci 2011, 56:2810-2817.
53. Klotz C., Ziegler T., Danilowicz-Luebert E., Hartmann S. Cystatins of parasitic organisms. Adv Exp Med Biol 2011, 712:208-221.
54. Klotz C., Ziegler T., Figueiredo A.S., Rausch S., Hepworth M.R., Obsivac N., Sers C., Lang R., Hammerstein P., Lucius R., et al. A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog 2011, 7:e1001248.
55. Donnelly S., O'Neill S.M., Stack C.M., Robinson M.W., Turnbull L., Whitchurch C., Dalton J.P. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem 2010, 285:3383-3392.
56. Dowling D.J., Hamilton C.M., Donnelly S., La Course J., Brophy P.M., Dalton J., O'Neill S.M. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun 2010, 78:793-801.